1Gyongyosi M,Yang P,Hassan A,et al.Coronary risk factors influence plaque morhpology in patients with unstable angina[].Coronary Artery Disease.1999
2Dupuis J,Tardif JC,Cernacek P,et al.Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes.the RECIFE(REduction of Cholesterol in Ischaemia and Function of the Endothelium)trial[].Circulation.1999
3Britten MB,Zeiher AM,Schachinger V.Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options[].Journal of Internal Medicine.1999
4Crea F,Biasucci LM,Buffon A,et al.Role of inflammation in the pathogenesis of unstable coronary artery disease[].The American Journal of Cardiology.1997
5Seres GL,Valle TV.Current prognosis of unstable angina.The results of clinical studies[].Revista Espanola de Cardiologia.1999
6Boyle JJ,Bennett MR,Proudfoot D,et al.Human monocyte/macrophages induce human vascular smooth muscle apoptosis in culture (substract)[].Journal of Paleopathology.1998
5Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.Circulation, 2006,113 ( 10 ):e409-449.
6Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med, 2004,350( 15 ):1495-1504.
7Plakogiannis R, Cohen H. Optimal low-density lipoprotein cholesterol lowering- morning versus evening statin administration. Ann Pharmacother, 2007,41 ( 1 ): 106-110.
8Sever P,Dahlof B,Pouher N, et al. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.Eur Heart J, 2006,27 (24):2982-2988.
9Larosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.N Engl J Med, 2005, 352( 14):1425-1435.
10Kapur NK.Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease. Expert Rev Cardiovasc Ther, 2007,5(2):161-175.
